Published in Clinical Oncology Week, August 18th, 2003
"Our results are encouraging because they affirm that oxaliplatin is safe for patients with advanced colorectal cancer," said Ramanathan, lead investigator and associate professor in the division of hematology/oncology at the University of Pittsburgh School of Medicine. "We found a relatively low occurrence of toxicity from treatment regimens that included oxaliplatin, indicating that it may be a promising option for colorectal patients."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.